535 related articles for article (PubMed ID: 28289036)
21. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009.
Morfin-Otero R; Dowzicky MJ
Clin Ther; 2012 Jan; 34(1):101-12. PubMed ID: 22177546
[TBL] [Abstract][Full Text] [Related]
22. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
[TBL] [Abstract][Full Text] [Related]
23. Comparative Antimicrobial Activity of Hp404 Peptide and Its Analogs against
Hong MJ; Kim MK; Park Y
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073939
[TBL] [Abstract][Full Text] [Related]
24. Octopromycin: Antibacterial and antibiofilm functions of a novel peptide derived from Octopus minor against multidrug-resistant Acinetobacter baumannii.
Rajapaksha DC; Jayathilaka EHTT; Edirisinghe SL; Nikapitiya C; Lee J; Whang I; De Zoysa M
Fish Shellfish Immunol; 2021 Oct; 117():82-94. PubMed ID: 34311097
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial and anti-biofilm potencies of dermcidin-derived peptide DCD-1L against Acinetobacter baumannii: an in vivo wound healing model.
Farshadzadeh Z; Pourhajibagher M; Taheri B; Ekrami A; Modarressi MH; Azimzadeh M; Bahador A
BMC Microbiol; 2022 Jan; 22(1):25. PubMed ID: 35026999
[TBL] [Abstract][Full Text] [Related]
26. Copper Resistance of the Emerging Pathogen Acinetobacter baumannii.
Williams CL; Neu HM; Gilbreath JJ; Michel SL; Zurawski DV; Merrell DS
Appl Environ Microbiol; 2016 Oct; 82(20):6174-6188. PubMed ID: 27520808
[TBL] [Abstract][Full Text] [Related]
27. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
Dowzicky MJ; Park CH
Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
[TBL] [Abstract][Full Text] [Related]
28. Silver nanoparticles synthesized with Eucalyptus critriodora ethanol leaf extract stimulate antibacterial activity against clinically multidrug-resistant Acinetobacter baumannii isolated from pneumonia patients.
Wintachai P; Paosen S; Yupanqui CT; Voravuthikunchai SP
Microb Pathog; 2019 Jan; 126():245-257. PubMed ID: 30445131
[TBL] [Abstract][Full Text] [Related]
29. Isolation and Characterization of a Novel
Wintachai P; Surachat K; Singkhamanan K
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215788
[TBL] [Abstract][Full Text] [Related]
30. Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii.
Hetta HF; Al-Kadmy IMS; Khazaal SS; Abbas S; Suhail A; El-Mokhtar MA; Ellah NHA; Ahmed EA; Abd-Ellatief RB; El-Masry EA; Batiha GE; Elkady AA; Mohamed NA; Algammal AM
Sci Rep; 2021 May; 11(1):10751. PubMed ID: 34031472
[TBL] [Abstract][Full Text] [Related]
31. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
Navon-Venezia S; Leavitt A; Carmeli Y
J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
[TBL] [Abstract][Full Text] [Related]
32. Minocycline--an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii.
Bishburg E; Bishburg K
Int J Antimicrob Agents; 2009 Nov; 34(5):395-401. PubMed ID: 19665876
[TBL] [Abstract][Full Text] [Related]
33. Effect of secondary metabolite of Actinidia deliciosa on the biofilm and extra-cellular matrix components of Acinetobacter baumannii.
Tiwari V; Tiwari D; Patel V; Tiwari M
Microb Pathog; 2017 Sep; 110():345-351. PubMed ID: 28705748
[TBL] [Abstract][Full Text] [Related]
34. Identification and bioevaluation of SRI-12742 as an antimicrobial agent against multidrug-resistant Acinetobacter baumannii.
Shukla M; Soni I; Matsuyama K; Tran T; Tanga M; Gong L; Chopra S
Int J Antimicrob Agents; 2018 Jul; 52(1):22-27. PubMed ID: 29501820
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds.
Morroni G; Simonetti O; Brenciani A; Brescini L; Kamysz W; Kamysz E; Neubauer D; Caffarini M; Orciani M; Giovanetti E; Offidani A; Giacometti A; Cirioni O
Med Microbiol Immunol; 2019 Dec; 208(6):877-883. PubMed ID: 31214759
[TBL] [Abstract][Full Text] [Related]
36. 5-Episinuleptolide Decreases the Expression of the Extracellular Matrix in Early Biofilm Formation of Multi-Drug Resistant Acinetobacter baumannii.
Tseng SP; Hung WC; Huang CY; Lin YS; Chan MY; Lu PL; Lin L; Sheu JH
Mar Drugs; 2016 Jul; 14(8):. PubMed ID: 27483290
[TBL] [Abstract][Full Text] [Related]
37. Chitosan as an effective inhibitor of multidrug resistant Acinetobacter baumannii.
Costa EM; Silva S; Vicente S; Veiga M; Tavaria F; Pintado MM
Carbohydr Polym; 2017 Dec; 178():347-351. PubMed ID: 29050604
[TBL] [Abstract][Full Text] [Related]
38. A novel series of enoyl reductase inhibitors targeting the ESKAPE pathogens, Staphylococcus aureus and Acinetobacter baumannii.
Kwon J; Mistry T; Ren J; Johnson ME; Mehboob S
Bioorg Med Chem; 2018 Jan; 26(1):65-76. PubMed ID: 29162308
[TBL] [Abstract][Full Text] [Related]
39. Acinetobacter baumannii isolated from hospital-acquired infection: biofilm production and drug susceptibility.
Krzyściak P; Chmielarczyk A; Pobiega M; Romaniszyn D; Wójkowska-Mach J
APMIS; 2017 Nov; 125(11):1017-1026. PubMed ID: 28913903
[TBL] [Abstract][Full Text] [Related]
40. SAR refinement of antileishmanial N(2),N(4)-disubstituted quinazoline-2,4-diamines.
Zhu X; Van Horn KS; Barber MM; Yang S; Wang MZ; Manetsch R; Werbovetz KA
Bioorg Med Chem; 2015 Aug; 23(16):5182-9. PubMed ID: 25749014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
